| __timestamp | ACADIA Pharmaceuticals Inc. | Amneal Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 60602000 | 335989000 |
| Thursday, January 1, 2015 | 76369000 | 367054000 |
| Friday, January 1, 2016 | 4406000 | 420770000 |
| Sunday, January 1, 2017 | 13060000 | 507476000 |
| Monday, January 1, 2018 | 18330000 | 946588000 |
| Tuesday, January 1, 2019 | 19598000 | 1273376000 |
| Wednesday, January 1, 2020 | 20550000 | 1364130000 |
| Friday, January 1, 2021 | 19141000 | 1324696000 |
| Saturday, January 1, 2022 | 10166000 | 1427596000 |
| Sunday, January 1, 2023 | 45731000 | 1573042000 |
Data in motion
In the ever-evolving pharmaceutical industry, understanding cost structures is crucial for assessing company performance. This analysis delves into the cost of revenue trends for Amneal Pharmaceuticals, Inc. and ACADIA Pharmaceuticals Inc. from 2014 to 2023.
Amneal Pharmaceuticals has shown a consistent upward trajectory in its cost of revenue, peaking at approximately $1.57 billion in 2023, marking a staggering 368% increase from 2014. This growth reflects Amneal's expanding operations and market reach. In contrast, ACADIA Pharmaceuticals experienced a more volatile pattern, with costs fluctuating significantly. Notably, ACADIA's cost of revenue in 2023 was around $45.7 million, a 24% decrease from its 2015 peak.
These trends highlight the contrasting business strategies and market dynamics faced by these two pharmaceutical giants, offering valuable insights for investors and industry analysts.
Cost of Revenue: Key Insights for GSK plc and ACADIA Pharmaceuticals Inc.
Cost of Revenue: Key Insights for Biogen Inc. and ACADIA Pharmaceuticals Inc.
Cost of Revenue Trends: Incyte Corporation vs Amneal Pharmaceuticals, Inc.
Viatris Inc. vs Amneal Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for Jazz Pharmaceuticals plc and Amneal Pharmaceuticals, Inc.
Cost Insights: Breaking Down Lantheus Holdings, Inc. and Amneal Pharmaceuticals, Inc.'s Expenses
Cost of Revenue: Key Insights for Amneal Pharmaceuticals, Inc. and PTC Therapeutics, Inc.
Comparing Cost of Revenue Efficiency: Amneal Pharmaceuticals, Inc. vs Amphastar Pharmaceuticals, Inc.
Cost of Revenue Trends: Xenon Pharmaceuticals Inc. vs ACADIA Pharmaceuticals Inc.
Cost of Revenue Trends: ACADIA Pharmaceuticals Inc. vs MorphoSys AG
Cost of Revenue: Key Insights for ACADIA Pharmaceuticals Inc. and Supernus Pharmaceuticals, Inc.
Comparing Cost of Revenue Efficiency: ACADIA Pharmaceuticals Inc. vs MiMedx Group, Inc.